Genovis (Q1 initial take): Sales and EBITDA in lin despite fx-headwinds - Redeye

Genovis delivered a Q1 report broadly in line with our estimates, meeting our sales projections showing 17% organic growth and EBITDA approximately 3% below our SEK9.8m projection, this despite cSEK4m in FX-headwinds during the quarter. We expect minor estimate revisions and anticipate a positive share price reaction at open.

Länk till analysen i sin helhet: https://www.redeye.se/research/1162041/genovis-q1-initial-take-sales-and-ebitda-in-lin-despite-fx-headwinds?utm_source=finwire&utm_medium=RSS